TrademarkDir
Serial #76312532
DEAD

Serial Number

76312532

Owner

Stressgen Biotechnologies Corporation

Attorney

Todd S. Bontemps, Esq.

Filing Date

Sep 14, 2001

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

Serial #76312532 Trademark

Serial Number: 76312532

Serial #76312532 is a trademark filed by Stressgen Biotechnologies Corporation on September 14, 2001. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Stressgen Biotechnologies Corporation (14 trademarks)

120-4243 Glanford Avenue
Victoria V8Z 4B9 , CA

Entity Type: 03

Trademark Details

Filing Date

September 14, 2001

Registration Date

Not Registered

Published for Opposition

August 27, 2002

Goods & Services

Research and development services in the field of pharmaceutical preparations used in diagnosis and treatment of cancer and infectious diseases

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Mar 10, 2005 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 10, 2005 ABN6
SOU EXTENSION 3 GRANTED
May 3, 2004 EX3G
CASE FILE IN TICRS
Apr 29, 2004 CFIT
ASSIGNED TO EXAMINER
Apr 26, 2004 DOCK
SOU EXTENSION 3 FILED
Apr 20, 2004 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 20, 2004 EEXT
SOU EXTENSION 2 GRANTED
Nov 19, 2003 EX2G
SOU EXTENSION 2 FILED
Nov 11, 2003 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 11, 2003 EEXT
SOU EXTENSION 1 GRANTED
Jun 13, 2003 EX1G
SOU EXTENSION 1 FILED
May 12, 2003 EXT1
PAPER RECEIVED
May 12, 2003 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 19, 2002 NOAM
PUBLISHED FOR OPPOSITION
Aug 27, 2002 PUBO
NOTICE OF PUBLICATION
Aug 7, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 16, 2002 CNSA
SEC. 44(D) CLAIM DELETED
Feb 20, 2002 44DD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 20, 2002 CRFA
NON-FINAL ACTION MAILED
Jan 28, 2002 CNRT
ASSIGNED TO EXAMINER
Dec 13, 2001 DOCK
ASSIGNED TO EXAMINER
Dec 7, 2001 DOCK

Related Trademarks

More from this Owner

INSIGHT TO IMPACT

INSIGHT TO IMPACT

INSIGHT TO IMPACT

INSIGHT TO IMPACT

NVENTA

NVENTA

COVAL

COVAL

COVAL

COVAL

COVAL

COVAL